Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
21.58
+0.30 (1.41%)
At close: Apr 30, 2026, 4:00 PM EDT
21.58
0.00 (0.00%)
Pre-market: May 1, 2026, 4:09 AM EDT
Bicara Therapeutics Market Cap
Bicara Therapeutics has a market cap or net worth of $1.41 billion as of May 1, 2026. Its market cap has increased by 127.69% in one year.
Market Cap
1.41B
Enterprise Value
999.69M
1-Year Change
127.69%
Ranking
Category
Stock Price
$21.58
Market Cap Chart
Since the IPO on September 13, 2024, Bicara Therapeutics's market cap has increased from $931.70M to $1.41B, an increase of 51.64%. That is a compound annual growth rate of 29.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 1.39B | 51.10% |
| Dec 31, 2025 | 921.98M | -2.74% |
| Dec 31, 2024 | 947.92M | 1.74% |
| Sep 13, 2024 | 931.70M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ardelyx | 1.46B |
| Immunocore Holdings | 1.46B |
| Damora Therapeutics | 1.46B |
| Agios Pharmaceuticals | 1.45B |
| Wave Life Sciences | 1.45B |
| Biohaven | 1.45B |
| Maze Therapeutics | 1.43B |
| Precigen | 1.42B |